August 4, 2020

US announces clinical trial of antibody treatment for COVID-19

Washington (AFP) – The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday.The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified in the blood sample of a recovered patient by Canada’s Abcellera Biologics. It was then developed synthetically for mass production by US-based Lilly Research Laboratories in partnership with Abcellera.The Phase 3 trial will initially enroll some 300 volunteers around the world who have been hospitalized with mild to moderate COVID-19 with fewer than 13 days of symptoms.Each…


Leave a Reply

Your email address will not be published. Required fields are marked *